CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, M. A.
Right arrow Articles by Gallinger, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, M. A.
Right arrow Articles by Gallinger, S.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 312-314, February 2006
© 2006 American Association for Cancer Research

Risk of Colorectal Cancer in Monoallelic and Biallelic Carriers of MYH Mutations: A Population-Based Case-Family Study

Mark A. Jenkins1, Marina E. Croitoru2, Neerav Monga4, Sean P. Cleary2, Michelle Cotterchio4, John L. Hopper1 and Steven Gallinger3,4

1 Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Victoria, Australia; 2 Samuel Lunenfeld Research Institute and 3 Department of Surgery, Mount Sinai Hospital; and 4 Cancer Care Ontario, Toronto, Ontario, Canada

Requests for reprints: Steven Gallinger, Department of Surgery, Mount Sinai Hospital, University of Toronto, Room 1225, 600 University Avenue, Toronto, Ontario, Canada. Phone: 416-586-8550; Fax: 416-586-8392. E-mail: sgallinger{at}rogers.com

Previous case-control studies have suggested that carriers of monoallelic germline mutations in the MYH gene may be at increased risk of colorectal cancer. We applied a kin-cohort design, using a modified segregation analysis, to estimate the colorectal cancer risk using 300 first-degree relatives of 39 colorectal cancer cases who were monoallelic or biallelic carriers of MYH mutations. We found that monoallelic carriers had a 3-fold increased risk of colorectal cancer (hazard ratio, 2.9; 95% confidence interval, 1.2-7.0; P = 0.02) and biallelic carriers a 50-fold increased risk (hazard ratio, 53; 95% confidence interval, 14-200; P < 0.0001). This analysis illustrates the potential of family analysis to estimate cancer risk for low-frequency mutations and, based on the proportion of relatives predicted to be carriers, we believe that this constitutes the largest study of monoallelic carriers to date. (Cancer Epidemiol Biomarkers Prev 2006;15(2):312–4)




This article has been cited by other articles:


Home page
GutHome page
J. Young, M. Jenkins, S. Parry, B. Young, D. Nancarrow, D. English, G. Giles, and J. Jass
Serrated pathway colorectal cancer in the population: genetic consideration
Gut, October 1, 2007; 56(10): 1453 - 1459.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Peterlongo, N. Mitra, A. S. d. Abajo, M. d. l. Hoya, C. Bassi, L. Bertario, P. Radice, E. Glogowski, K. Nafa, T. Caldes, et al.
Increased frequency of disease-causing MYH mutations in colon cancer families
Carcinogenesis, November 1, 2006; 27(11): 2243 - 2249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.